Anticancer Drugs

• Application
• Other, Pharmaceutical, Oncology

• Dosage Form
• Tablet

• Enzymatic Activity
• Inhibits aromatase enzyme activity

• Enzyme Types
• Other, Aromatase inhibitor

• Feature
• Other, Film-coated, easy to swallow, precise dosage

• Fermentation Smell
• Other, Odorless

• Indication
• Used for treatment of breast cancer in postmenopausal women

• Ingredients
• Other , Anastrozole, excipients

• Physical Color/Texture
• Other , White to off-white, round tablets

• Salt Composition
• Anastrozole 1 mg

• Shelf Life
• 24 to 36 months

• Storage Instructions
• Store below 25C, protect from moisture

• Shelf Life
• 3 Years

• Enzyme Types
• Other

• Shelf Life
• 3 Years

• Shelf Life
• 3 Years

• Application
• Other

• Ingredients
• Other

• Shelf Life
• 3 Years

• Application
• Other, Oral chemotherapy for cancer treatment

• Dosage Form
• Tablet

• Enzyme Types
• Other, Not applicable (Capecitabine is an antineoplastic agent, not an enzyme)

• Feature
• Other, Film-coated, easy to swallow, available in multiple strengths

• Fermentation Smell
• Other, Odorless or slight medicinal odor

• Indication
• Treatment of metastatic breast cancer, colorectal cancer, other advanced or metastatic cancers

• Ingredients
• Other , Capecitabine and inactive excipients

• Physical Color/Texture
• Other , Light peach to pink, film-coated tablets

• Salt Composition
• Capecitabine

• Shelf Life
• 2436 months from date of manufacture

• Storage Instructions
• Store below 30C, in a dry place, protected from light

• Application
• Other, Oncology, Anticancer Therapy

• Dosage Form
• Tablet

• Feature
• Other, Oral therapy for specific cancers, precise dosing, improved quality of life in cancer patients

• Fermentation Smell
• Other, Odorless

• Indication
• Chronic Myeloid Leukemia, Gastrointestinal Stromal Tumors, Ph+ Acute Lymphoblastic Leukemia, Dermatofibrosarcoma Protuberans

• Ingredients
• Other , Imatinib Mesylate and excipients

• Physical Color/Texture
• Other , Yellow to brownish-orange, film-coated tablet

• Salt Composition
• Imatinib Mesylate

• Shelf Life
• 24 months

• Storage Instructions
• Store below 30C in a dry place, protect from light and moisture

• Application
• Other

• Dosage Form
• Tablet

• Feature
• Other

• Indication
• Treatment of acute lymphoblastic leukemia (ALL), chronic myeloid leukemia (CML), and other specified hematologic malignancies

• Ingredients
• Other

• Physical Color/Texture
• Other

• Salt Composition
• Mercaptopurine 50 mg

• Shelf Life
• 24-36 months Months

• Storage Instructions
• Store below 25 C, protect from light and moisture

• Application
• Other, Treatment of specific cancers

• Dosage Form
• Capsule

• Enzyme Types
• Other, None (Not enzyme-based)

• Feature
• Other, Oral anticancer agent, immunomodulatory

• Fermentation Smell
• Other, Odorless (no fermentation)

• Indication
• Multiple myeloma, Myelodysplastic syndromes

• Ingredients
• Other , Lenalidomide, Excipients

• Physical Color/Texture
• Other , White to off-white capsules

• Salt Composition
• Lenalidomide

• Shelf Life
• 24-36 months

• Storage Instructions
• Store below 25C, dry place, away from light

• Application
• Other, Intravenous use in hospital or clinical settings.

• Dosage Form
• Injection

• Feature
• Other, Ready-to-use infusion bag; single dose; preservative free

• Indication
• Used for treatment of osteoporosis, Pagets disease of bone, hypercalcemia of malignancy, and bone metastases.

• Ingredients
• Other , Zoledronic Acid Monohydrate, Mannitol, Sodium Citrate, Water for Injection

• Ph Level
• Between 6.0 and 7.0

• Physical Color/Texture
• Other , Clear, colorless, sterile solution

• Salt Composition
• Zoledronic Acid 5 mg/100 ml

• Shelf Life
• 24 months

• Storage Instructions
• Store below 30C, do not freeze, protect from light.